Switzerland · Delayed Price · Currency is CHF DocMorris AG Statistics
Total Valuation
DocMorris AG has a market cap or net worth of CHF 502.62 million. The enterprise value is 669.10 million.
| Market Cap | 502.62M |
| Enterprise Value | 669.10M |
Important Dates
The last earnings date was Wednesday, August 19, 2026.
| Earnings Date | Aug 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
DocMorris AG has 50.49 million shares outstanding. The number of shares has increased by 135.61% in one year.
| Current Share Class | 50.49M |
| Shares Outstanding | 50.49M |
| Shares Change (YoY) | +135.61% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | 0.54% |
| Owned by Institutions (%) | 37.83% |
| Float | 38.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.43 |
| PB Ratio | 1.40 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.57 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.87, with a Debt / Equity ratio of 0.74.
| Current Ratio | 1.87 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.74 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.82 |
| Interest Coverage | -4.92 |
Financial Efficiency
Return on equity (ROE) is -30.05% and return on invested capital (ROIC) is -16.36%.
| Return on Equity (ROE) | -30.05% |
| Return on Assets (ROA) | -6.37% |
| Return on Invested Capital (ROIC) | -16.36% |
| Return on Capital Employed (ROCE) | -13.44% |
| Weighted Average Cost of Capital (WACC) | 11.27% |
| Revenue Per Employee | 884,200 |
| Profits Per Employee | -94,197 |
| Employee Count | 1,576 |
| Asset Turnover | 1.40 |
| Inventory Turnover | 20.26 |
Taxes
In the past 12 months, DocMorris AG has paid 13.42 million in taxes.
| Income Tax | 13.42M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +41.39% in the last 52 weeks. The beta is 1.86, so DocMorris AG's price volatility has been higher than the market average.
| Beta (5Y) | 1.86 |
| 52-Week Price Change | +41.39% |
| 50-Day Moving Average | 9.52 |
| 200-Day Moving Average | 6.74 |
| Relative Strength Index (RSI) | 51.49 |
| Average Volume (20 Days) | 314,316 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, DocMorris AG had revenue of CHF 1.18 billion and -125.94 million in losses. Loss per share was -2.61.
| Revenue | 1.18B |
| Gross Profit | 261.25M |
| Operating Income | -85.76M |
| Pretax Income | -112.52M |
| Net Income | -125.94M |
| EBITDA | -75.62M |
| EBIT | -85.76M |
| Loss Per Share | -2.61 |
Balance Sheet
The company has 99.20 million in cash and 265.68 million in debt, with a net cash position of -166.48 million or -3.30 per share.
| Cash & Cash Equivalents | 99.20M |
| Total Debt | 265.68M |
| Net Cash | -166.48M |
| Net Cash Per Share | -3.30 |
| Equity (Book Value) | 357.89M |
| Book Value Per Share | 7.41 |
| Working Capital | 120.24M |
Cash Flow
In the last 12 months, operating cash flow was -54.03 million and capital expenditures -1.10 million, giving a free cash flow of -55.13 million.
| Operating Cash Flow | -54.03M |
| Capital Expenditures | -1.10M |
| Depreciation & Amortization | 10.15M |
| Net Borrowing | -55.33M |
| Free Cash Flow | -55.13M |
| FCF Per Share | -1.09 |
Margins
Gross margin is 22.10%, with operating and profit margins of -7.25% and -10.65%.
| Gross Margin | 22.10% |
| Operating Margin | -7.25% |
| Pretax Margin | -9.52% |
| Profit Margin | -10.65% |
| EBITDA Margin | -6.40% |
| EBIT Margin | -7.25% |
| FCF Margin | n/a |
Dividends & Yields
DocMorris AG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -135.61% |
| Shareholder Yield | -135.61% |
| Earnings Yield | -25.06% |
| FCF Yield | -10.97% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for DocMorris AG is 10.92, which is 11.09% higher than the current price. The consensus rating is "Buy".
| Price Target | 10.92 |
| Price Target Difference | 11.09% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 10.60% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DocMorris AG has an Altman Z-Score of 0.37 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.37 |
| Piotroski F-Score | 4 |